We were also able to show that the molecular targets through which these drugs exert their growth-inhibitory effects, namely PLK-1, PI3K, mTOR, BCL-2, BCL-xL, and MCL-1, are expressed in MM cells. This evidence concerns the gene BCL2 and Miyoshi myopathy.